Researchers receive two grants to study tuberculosis drug development

Weill Cornell Medicine researchers and the TB Drug Accelerator have received two grants totaling $6.8 million from the Bill & Melinda Gates Foundation to study tuberculosis (TB) drug development.

Related Keywords

,Michael Glickman ,Sabine Ehrt ,Carlf Nathan ,Dirk Schnappinger ,Laboratory Of Host ,World Health Organization ,Pathogen Biology At Rockefeller University ,Melinda Gates Foundation ,Sloan Kettering Institute ,Cornell Medicine ,Weill Cornell Medicine ,World Health ,Jeremy Rock ,Host Pathogen Biology ,Medicine ,Tuberculosis ,Bacteria ,Chest Pain ,Dough ,Drugs ,Fever ,Gene ,Mmunology ,Infectious Diseases ,Lungs ,Icrobiology ,Olecule ,Rain ,Athogen ,Research ,Small Molecules ,